Sutter Health Research Enterprise
2340 Clay Street
San Francisco, CA, 94115
(415) 600-1020
ClinicalResearch@sutterhealth.org
Sutter Health Research Enterprise
2340 Clay Street
San Francisco, CA, 94115
(415) 600-1020
ClinicalResearch@sutterhealth.org
Primary Research Interests
Related Clinical Trials
ASSURE (Coming Soon)
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD
ELATIVE
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)
Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD
Status: Active, Recruiting
InFUSE
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
Investigators: Todd Frederick M.D., Edward Holt MD, Raphael Merriman MD
Status: Active, Recruiting
MIRUM
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) (VIST
Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD
Status: Active, Recruiting
RESPONSE
RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA
Investigators: Edward Holt MD, Raphael Merriman MD, Kidist Yimam MD
Status: Active, Recruiting